Your browser doesn't support javascript.
loading
Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma.
Usmani, S Z; Cavenagh, J D; Belch, A R; Hulin, C; Basu, S; White, D; Nooka, A; Ervin-Haynes, A; Yiu, W; Nagarwala, Y; Berger, A; Pelligra, C G; Guo, S; Binder, G; Gibson, C J; Facon, T.
Afiliação
  • Usmani SZ; a a Levine Cancer Institute/Carolinas Healthcare System , Charlotte, NC , USA.
  • Cavenagh JD; b b St. Bartholomew's Hospital , West Smithfield, London , UK.
  • Belch AR; c c Cross Cancer Institute , University of Alberta , Edmonton, AB , Canada.
  • Hulin C; d d Bordeaux Hospital University Center (CHU) , Bordeaux , France.
  • Basu S; e e Royal Wolverhampton Hospitals NHS Trust , Wolverhampton , UK.
  • White D; f f Dalhousie University and QEII Health Sciences Center , Halifax, NS , Canada.
  • Nooka A; g g Winship Cancer Institute , Emory University , Atlanta , GA , USA.
  • Ervin-Haynes A; h h Celgene Corporation , Summit, NJ , USA.
  • Yiu W; h h Celgene Corporation , Summit, NJ , USA.
  • Nagarwala Y; h h Celgene Corporation , Summit, NJ , USA.
  • Berger A; i i Evidera , Lexington, MA , USA.
  • Pelligra CG; i i Evidera , Lexington, MA , USA.
  • Guo S; i i Evidera , Lexington, MA , USA.
  • Binder G; h h Celgene Corporation , Summit, NJ , USA.
  • Gibson CJ; h h Celgene Corporation , Summit, NJ , USA.
  • Facon T; j j Service des Maladies du Sang , Hôpital Huriez , CHRU Lille, Lille , France.
J Med Econ ; 19(3): 243-58, 2016.
Article em En | MEDLINE | ID: mdl-26517601

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Melfalan / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Health_economic_evaluation Limite: Aged / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Bortezomib / Melfalan / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Health_economic_evaluation Limite: Aged / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article